ITPRIPL1 and non-small cell lung carcinoma: To precisely evaluate the ITPRIPL1 expression in NSCLC patients, we collected 75 groups of paired patient tissue samples (the tumor tissue and respective paracancerous tissue) and performed immunohistochemistry with our anti-ITPRIPL1 antibody.